CME Group (CME) FY2012 results: revenue $2.9 billion, down 11.2% on the year
CME Group Inc. (CME) reported revenue of $2.9 billion for fiscal 2012, the year ended 31 December 2012, down 11.2% on the year before. Net income was $896 million, down 50.5%, and diluted earnings per share $2.70. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2013.
Revenue
$2.9 billion
-11.2% on the year
FY2007FY2012
Operating margin
58.1%
61.6% a year earlier
FY2007FY2012
Net income
$896 million
-50.5% on the year
FY2007FY2012
Diluted EPS
$2.70
-50.3% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
2,915
3,281
3,004
-11.2%
Operating income
1,692
2,021
1,831
-16.3%
Operating margin
58.1%
61.6%
61.0%
Pre-tax income
1,693
1,936
1,722
-12.6%
Income tax
787
122
770
+544.3%
Effective tax rate
46.5%
6.3%
44.7%
Net income
896
1,812
951
-50.5%
Net margin
30.8%
55.2%
31.7%
Diluted EPS
$2.70
$5.43
$2.86
-50.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
1,220
1,346
1,360
-9.4%
Capital expenditure
142
172
160
-17.7%
Free cash flow
1,078
1,174
1,200
-8.2%
Free cash flow margin
37.0%
35.8%
39.9%
Cash from investing
-209
-154
-112
Cash from financing
-448
-1,006
-653
Depreciation and amortisation
137
128
130
+6.5%
Share-based compensation
61.4
51.3
40.9
+19.7%
Buybacks
0.0
220
575
Dividends paid
1,224
373
305
+228.4%
Dividend per share
$3.70
$0.22
$0.18
+1,551.8%
Diluted shares, weighted
332m
334m
332m
-0.4%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
21,419
21,552
20,060
-0.6%
Non-controlling interest
5.8
0.0
n/a
Redeemable equity
80.8
70.3
n/a
+14.9%
Short-term borrowings
n/a
0.0
n/a
Debt
2,856
2,107
2,525
+35.6%
Other liabilities
14,501
17,030
12,461
-14.8%
Total liabilities and equity
38,863
40,759
35,046
-4.7%
Fixed assets
724
822
787
-11.9%
Goodwill
7,567
7,984
7,984
-5.2%
Intangible assets
2,854
3,313
3,453
-13.9%
Investments
56.6
47.6
50.2
+18.9%
Trading assets
38.7
31.8
28.8
+21.7%
Cash and equivalents
1,605
1,042
855
+54.0%
Receivables
268
289
298
-7.6%
Other assets
25,751
27,229
21,591
-5.4%
Total assets
38,863
40,759
35,046
-4.7%
10-K for the year ended 31 December 2012, filed 1 March 2013: the filing.